Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Atul T Patel

14PUBLICATIONS
28CO-AUTHORS
Toxicology (incl. clinical toxicology)Prosthetics and orthoticsTraditional Chinese medicine and treatmentsOrthopticsOrthodontics and dentofacial orthopaedics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

Sort by Publication Date:
|May 20, 2026
A Phase IV, Randomized, Double-Blind, Crossover Study to Compare the Clinical Safety and Efficacy of AbobotulinumtoxinA and OnabotulinumtoxinA in Adult Upper Limb Spasticity.

|Feb 26, 2026
Impact of Early Versus Late Treatment with Botulinum Toxin A on Goal Attainment in Post-Stroke Spasticity: A Retrospective Cohort Study.

Atul Patel, Jinming Zhang, Simon Page

|Feb 12, 2026
Real-World Retrospective Safety Analysis of OnabotulinumtoxinA for the Treatment of Patients with Chronic Migraine and Concomitant Therapeutic Indications.

Andrew M Blumenfeld, Christopher Rhyne, Kenneth Martinez

|Aug 21, 2025
Reply to letter re: "A randomized, double-blind, placebo-controlled trial of daxibotulinumtoxinA for injection for the treatment of upper limb spasticity in adults after stroke or traumatic brain injury".

Atul T Patel, Michael C Munin, Ziyad Ayyoub

|Mar 26, 2025
Efficacy Remaining at Time of Requested Re-Treatment for Cervical Dystonia: A Potential New Treatment Paradigm with DaxibotulinumtoxinA.

Aaron Ellenbogen, Robert A Hauser, Atul T Patel

|Oct 25, 2024
SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.

Grace Forde, Benjamin M Brucker, Kimberly Becker Ifantides

Pageof 3

Frequent Collaborators

2 joint publications

Simon Page

2 joint publications

Mathieu Beneteau

2 joint publications

Alberto Esquenazi

2 joint publications

Theodore Wein

2 joint publications

Ziyad Ayyoub

1 joint publications

Kim Becker Ifantides

1 joint publications

Simona Battucci

1 joint publications

Marc Schwartz

1 joint publications

Jinming Zhang

1 joint publications

Colin Navickas

Frequent Collaborators

2 joint publications

Simon Page

2 joint publications

Mathieu Beneteau

2 joint publications

Alberto Esquenazi

2 joint publications

Theodore Wein